Tissue engineering of oral mucosa: a shared concept with skin

Date

2015-03-01

Author

Kinikoglu, Beste
Damour, Odile
Hasırcı, Vasıf Nejat

Metadata

Show full item record

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Item Usage Stats

274
views

0
downloads

Tissue-engineered oral mucosa, in the form of epithelial cell sheets or full-thickness oral mucosa equivalents, is a potential solution for many patients with congenital defects or with tissue loss due to diseases or tumor excision following a craniofacial cancer diagnosis. In the laboratory, it further serves as an in vitro model, alternative to in vivo testing of oral care products, and provides insight into the behavior of the oral mucosal cells in healthy and pathological tissues. This review covers the old and new generation scaffold types and materials used in oral mucosa engineering; discusses similarities and differences between oral mucosa and skin, the methods developed to reconstruct oral mucosal defects; and ends with future perspectives on oral mucosa engineering.

Subject Keywords

Tissue engineering, Biomaterials, Polymeric scaffold, Oral mucosa, Skin

URI

https://hdl.handle.net/11511/30293

Journal

JOURNAL OF ARTIFICIAL ORGANS

DOI

https://doi.org/10.1007/s10047-014-0798-5

Collections

Graduate School of Natural and Applied Sciences, Article

Suggestions

OpenMETU
Core

Tissue engineering of full-thickness human oral mucosa Kınıkoğlu, Beste; Hasırcı, Vasıf Nejat; Damour, Odile; Department of Biotechnology (2010) Tissue engineered human oral mucosa has the potential to fill tissue deficits caused by facial trauma or malignant lesion surgery. It can also help elucidate the biology of oral mucosa and serve as an alternative to in vivo testing of oral care products. The aim of this thesis was to construct a tissue engineered full-thickness human oral mucosa closely mimicking the native tissue. To this end, the feasibility of the concept was tested by co-culturing fibroblasts and epithelial cells isolated from normal hu...
Feasibility of a porcine oral mucosa equivalent: A preclinical study Kinikoglu, Beste; Hemar, Julie; Hasırcı, Vasıf Nejat; Breton, Pierre; Damour, Odile (2012-08-01) Oral tissue engineering aims to treat and fill tissue deficits caused by congenital defects, facial trauma, or malignant lesion surgery, as well as to study the biology of oral mucosa. The Food and Drug Administration (FDA) and the European Medicines Agency (EMA) require a large animal model to evaluate cell-based devices, including tissue-engineered oral mucosa, prior to initiating human clinical studies. Porcine oral mucosa is non-keratinized and resembles that of humans more closely than any other animal...
Additive manufacturing of biodegradable magnesium implants and scaffolds: Review of the recent advances and research trends Sezer, Nurettin; Evis, Zafer; Koc, Muammer (2021-03-01) Synthetic grafting needs improvements to eliminate secondary surgeries for the removal of implants after healing of the defected tissues. Tissue scaffolds are engineered to serve as temporary templates, which support the affected tissue and gradually degrade through the healing period. Beside mechanical function to withstand the anatomic loading conditions, scaffolds should also provide a decent biological function for the diffusion of nutrients and oxygen to the cells, and excretion of the wastes from the ...
Studies directed towards The synthesis Of İmatinib Mesylate ((Gleevec), 4-(4-Methyl-Piperazin-1- Ylmethyl)-N-[4- Methyl-3-(4-Pyridin-3-Yl-Pyrimidin-2- Ylamino)-Phenyl]- Benzamide Methanesulfonate) Analogs Günay, Neşet Batuhan; Demir, Ayhan Sıtkı; Department of Chemistry (2008) Imatinib mesylate is indicated for the treatment of chronic myeloid leukemia (CML) and unresectable and/or metastatic malignant gastrointestinal stromal tumors (GIST). By the application of this anticancer drug, problems occurs in terms of stability and activity. Computer assisted design (CAD) works showed that the modification of the B and C part molecule can increase the effectivity of the drug. The new derivatives of the drug will be obtained to change some part of the B and C segments. The total synthes...
Upregulation of multi drug resistance genes in doxorubicin resistant human acute myelogeneous leukemia cells and reversal of the resistance BARAN, YUSUF; Guer, Bala; Kaya, Pelin; Ural, Ali Ugur; Avcu, Ferit; Gündüz, Ufuk (2007-12-01) The major problem in the treatment of acute myeloid leukemia (AML) patients results from multidrug resistance to administered anticancer agents. Drug resistance proteins, MDR1 and MRP1, which work as drug efflux pumps, can mediate the multidrug resistance of human leukemia cells. In this study, the mechanisms of resistance to doxorubicin-induced cell death in human HL60 AML cells were examined.

Citation Formats

B. Kinikoglu, O. Damour, and V. N. Hasırcı, “Tissue engineering of oral mucosa: a shared concept with skin,” JOURNAL OF ARTIFICIAL ORGANS, pp. 8–19, 2015, Accessed: 00, 2020. [Online]. Available: https://hdl.handle.net/11511/30293.